1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
  4. > Global Medical Biotechnology Analysis & Statistics

Global Medical Biotechnology Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Renub Research

All regions

1-10 of 10 reports

CAR T Cell Therapy Market Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study, Companies

  • $ 2390
  • June 2020
  • 167 pages

CAR T Cell Therapy Market Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study, Companies For many years, the support of cancer therapy was chemotherapy, surgery and radiation therapy. However, ...

  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • World
  • Market Size

Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies

  • $ 1790
  • January 2020
  • 170 pages

Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies Increasing prevalence of Infectious diseases such as Influenza, HPV, Hepatitis, HIV and Tuberculosis ...

  • Medical Biotechnology
  • World
  • Forecast
  • Market Shares
  • Market Size

Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable

  • $ 2295
  • April 2019
  • 226 pages

Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable Next Generation Sequencing (NGS) is a recent ...

  • Diagnostics
  • Genome Sequencing
  • Molecular Diagnostics
  • World
  • Forecast

CAR T Cell Therapy Market Global Forecast by Regions, Targeted Antigens Clinical Trials/Study Companies, Celgene Corporation, Celyad)

  • $ 2390
  • August 2018
  • 159 pages

CAR T Cell therapy market is expected to grow with a CAGR of over 46 percent in the forecast period. Year 2017 has created new milestone for the oncology patients as FDA approved the first two CD19-targeted ...

  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • World
  • Market Size

Liquid Biopsy Market, Global Analysis by Cancer, Product, Circulating Biomarkers, Circulating Tumor DNA & Exosomes, Sample, Clinical Application, Regions, Companies

  • $ 1990
  • August 2018
  • 138 pages

Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy ...

  • Biotech Diagnostics
  • Medical Biotechnology
  • World
  • Company Financials
  • Market Size

Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies

  • $ 1790
  • July 2018
  • 174 pages

Global Molecular Diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed ...

  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • World
  • Market Size

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast

  • $ 1790
  • May 2018
  • 309 pages

Global Cervical Cancer Screening Market is projected to reach US$ 7 Billion by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women ove ...

  • Medical Biotechnology
  • Sexually Transmitted Disease
  • World
  • Demographic
  • Forecast

Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies

  • $ 1500
  • July 2017
  • 105 pages

Cardiac Maker Analyzer – Product Analysis Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the ...

  • Medical Biotechnology
  • World
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast

  • $ 1990
  • February 2017
  • 238 pages

Global Cervical Market is expected to be close to US$ 7 Billion by 2020. North America controls almost 50 percent Cervical Cancer Market. United States and Japan together makes more than 50 percent market ...

  • Medical Biotechnology
  • Southeast Asia
  • World
  • Demographic
  • Forecast

Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)

  • $ 1250
  • January 2017
  • 121 pages

Cervical cancer test market in Asian region is growing and expected to cross over Billion dollars by 2020. Despite declining women population, Japan has highest market share in cervical cancer test market. ...

  • Cancer Diagnostics
  • Medical Biotechnology
  • Sexually Transmitted Disease
  • World
  • Forecast



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on